5 March 2018 - Deborah Wilkes
Archived
Sweden's Moberg Pharma is divesting the Balmex range of nappy rash products in the US to Randob Labs for USD4.25 million plus the inventory value at closing.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.